Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate (Q46453980)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2008
edit
Language Label Description Also known as
English
Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate
scientific article published in August 2008

    Statements

    Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit